OWLO
Owlo is a Paris-based spin-off company from Institut Langevin (ESPCI Paris, CNRS) founded in 2024, specializing in next-generation non-invasive microscopy technology for healthcare. Their patented innovation enables real-time 3D imaging deep within biological tissues by shifting complexity from hardware to software, compatible with any standard microscope. Owlo's technology integrates advanced wave physics algorithms and AI to provide unprecedented resolution and biomarker extraction, targeting applications in IVF, drug discovery, and ophthalmology. The company aims to improve clinical decisions and patient outcomes with its unique 3D visualization and AI-enhanced data capabilities, positioning itself as a pioneer in deep tissue optical imaging.
OWLO
Owlo is a Paris-based spin-off company from Institut Langevin (ESPCI Paris, CNRS) founded in 2024, specializing in next-generation non-invasive microscopy technology for healthcare. Their patented innovation enables real-time 3D imaging deep within biological tissues by shifting complexity from hardware to software, compatible with any standard microscope. Owlo's technology integrates advanced wave physics algorithms and AI to provide unprecedented resolution and biomarker extraction, targeting applications in IVF, drug discovery, and ophthalmology. The company aims to improve clinical decisions and patient outcomes with its unique 3D visualization and AI-enhanced data capabilities, positioning itself as a pioneer in deep tissue optical imaging.